Stockscreener 앱 받기
16.14
4.20%
0.65
시장 영업 전:
16.01
-0.13
-0.81%
Optimizerx Corp 주식(OPRX)의 최신 뉴스
OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
OptimizeRx announces leadership reorganization to drive growth strategy - Investing.com
OptimizeRx Corp. Announces Leadership Changes to Enhance Growth Strategy and Profitability - Quiver Quantitative
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth - MarketScreener
Major C-Suite Overhaul: OptimizeRx Names 6 Top Executives to New Roles in Healthcare Tech Growth Push - Stock Titan
OptimizeRx Corporation Attempts Reversal From Key SupportQuarterly Performance Summary & Reliable Entry Point Alerts - 선데이타임즈
Regression analysis insights on OptimizeRx Corporation performanceMarket Sentiment Summary & Accurate Buy Signal Alerts - Newser
How moving averages guide OptimizeRx Corporation tradingWeekly Profit Summary & Step-by-Step Swing Trade Plans - Newser
Short interest data insights for OptimizeRx CorporationGlobal Markets & Reliable Intraday Trade Plans - Newser
OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
JMP Securities Forecasts Strong Price Appreciation for OptimizeRx (NASDAQ:OPRX) Stock - MarketBeat
Trend analysis for OptimizeRx Corporation this weekWeekly Profit Analysis & Verified Swing Trading Watchlists - Newser
Can you recover from losses in OptimizeRx Corporation2025 Key Lessons & Weekly High Potential Stock Alerts - Newser
Will breakout in OptimizeRx Corporation lead to full recoveryJuly 2025 PreEarnings & Capital Efficient Trade Techniques - Newser
What technical models suggest about OptimizeRx Corporation’s comebackForecast Cut & Stock Market Timing Techniques - Newser
OptimizeRx’s SWOT analysis: digital health firm’s stock faces scaling hurdles - Investing.com
OptimizeRx Reports 55% YoY Revenue Growth, Raises 2025 Guidance - AInvest
OptimizeRx (NASDAQ:OPRX) Given New $18.00 Price Target at Stifel Nicolaus - MarketBeat
OptimizeRx Corporation (NASDAQ:OPRX) Q2 2025 Earnings Call Transcript - Insider Monkey
Is OptimizeRx Corporation stock bottoming outTechnical Trend Forecast for Investors - Newser
OptimizeRX price target raised to $20 from $14 at JMP on strong earnings - Investing.com Nigeria
What makes OptimizeRx Corporation stock price move sharplySwing Trade Timing with Daily Forecast - Newser
Using AI based signals to follow OptimizeRx CorporationSteady Return Plan Based on Data Analysis - Newser
Should you hold or exit OptimizeRx Corporation nowTechnical Screener for High Growth Stocks - Newser
Blair William & Co. IL Buys 29,648 Shares of OptimizeRx Corp. (NASDAQ:OPRX) - MarketBeat
Applying Elliott Wave Theory to OptimizeRx CorporationShort Term Gain Strategy with AI Logic - Newser
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates - MSN
Advanced analytics toolkit walkthrough for OptimizeRx CorporationTechnical Reversal Pattern Summary and Tracker - Newser
OptimizeRx Reports Strong Q2 2025 Financial Growth - The Globe and Mail
Healthcare Stocks Move in Friday's Pre-Market Session: OptimizeRx, Embecta, and More - AInvest
OptimizeRx Corp Surpasses Q2 2025 Estimates with 55% Revenue Increase, Achieves GAAP Net Income of $1.5M - AInvest
Stifel Nicolaus Keeps Buy Rating on OptimizeRx with $18 Price Target. - AInvest
OptimizeRx (OPRX): A High-Growth Digital Pharma Play with Explosive Q2 Earnings and Strong Balance Sheet - AInvest
Optimizerx (OPRX.O) Surges 35.67% — What’s Fueling the Intraday Spike? - AInvest
Optimizerx (OPRX.O) Surges 16%—What’s Behind the Sudden Move? - AInvest
Stifel raises Optimizerx PT to $18, maintains Buy rating. - AInvest
Earnings call transcript: OptimizeRx Q2 2025 sees EPS surprise, stock jumps - Investing.com Canada
OptimizeRx Corp (OPRX) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance - The Manila Times
OptimizeRx Corp reports results for the quarter ended June 30Earnings Summary - TradingView
OptimizeRx Stock Rallies 22% After-Hours Thanks To Q2 Earnings Push - inkl
OPTIMIZERx earnings beat by $0.22, revenue topped estimates - Investing.com
OptimizeRx Q2 rev up 55% YoY to $29.2mln, raises FY25 guidance. - AInvest
Press Release: OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance - 富途牛牛
0.12%
1.30%
자본화:
|
볼륨(24시간):